{"name":"Dexcel Pharma Technologies Ltd.","slug":"dexcel-pharma-technologies-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PerioChip ®","genericName":"PerioChip ®","slug":"periochip","indication":"Adjunctive treatment of adult periodontitis","status":"marketed"}]}],"pipeline":[{"name":"PerioChip ®","genericName":"PerioChip ®","slug":"periochip","phase":"marketed","mechanism":"PerioChip releases chlorhexidine directly into periodontal pockets to reduce bacterial infection and inflammation in periodontal disease.","indications":["Adjunctive treatment of adult periodontitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOR01rWl9Fb3hNcmdDMWppNmF2cUJBdEdNS3ljU1NGZkZtVU81TUZ2ZDJYZndnZy0yVnl0ck91R1V6UEVaREN1Z2E3QTNpcUpCRUNvTi1qUV9WMXAwQTNiSGRHRF9ZQ2otaEQybkZhcnNjOWZsRWV0ZGhUNWd0THFCRkQ4YUp6c25YRjQxYzBJNkRPbGxGY1NSdmlTNjFUaGNGMGczM0VR?oc=5","date":"2026-01-07","type":"deal","source":"prnewswire.com","summary":"Dexcel Pharma USA Acquires US Rights to Zubsolv® - prnewswire.com","headline":"Dexcel Pharma USA Acquires US Rights to Zubsolv®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9pS0R2QmtQR3MyZUVEV0daSVYzQ1paNFAyY1RGa2FWMk1xQ2ZyT1RKbFJ1bTBVSlN0UzVwTTZseUliRnFxTUp3ckh3RTRMcWRIQVhZTGpUQ1lvUWFvZGFUS1N6WWxqU1Nm?oc=5","date":"2025-12-21","type":"pipeline","source":"calcalistech.com","summary":"Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses - calcalistech.com","headline":"Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPa2gzTWFITlRTcFFkS09wT0Fna1RmX0FFN0JabHhyZ0loZjdCaG81SVQ0clpzLW5DbG5oZmFQeWpJc09fWWdFQUFtNHZ0ZW8xME02Y2pRU0hSWXRHQ3hNQ0tfenc3d3BTeS1aeGVaY2tfcjdKQXpLYjNicGhKeUQ5M3ZaUnZqVTd1cEJGZGFiLVYxVzVrYkQweHU1cTZnNS1FQ3pwUTk1SUFtck9BZ2R0ZE5hMUZocWhYVlJ2Qjc5ZnJJNVNoQ1NYNg?oc=5","date":"2025-12-18","type":"pipeline","source":"BioCentury","summary":"Third Rock backs Steve Paul’s latest schizophrenia spinout in $165M round: Venture Report - BioCentury","headline":"Third Rock backs Steve Paul’s latest schizophrenia spinout in $165M round: Venture Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxQUy00YjlTS1R0SEYwY3BmTWFWV1lISzNRczlqSTN6RHFrLW5kWlBfUU04c05jTHczc1NnOUVHT1FGaWZRZmZJLTFSd0pFbXgzLXIycFpfOHJCVnV6ZDJxVEpzT3BSSklfMDNrWTJibHlTUjJDaTRLMlNfZS1oSU9tS3ZFTHZqM3hGdkN0b0pTT2J0WFNHRG1IcEpBNmZpOWlTMmJfOWUwck80TS03aW9lbjhYdEZHVXdqN2pTcVJ2d1lSNENlQVp1ZlBoNDhnSmxrdURsOFJsYkIyVTFCMmREUFVuN3hpX1hlVnB4dHAxMlZjckU1U1Qw?oc=5","date":"2024-11-29","type":"pipeline","source":"NTB Kommunikasjon","summary":"Strides Pharma Consolidates European Business-to-Business Operations in Switzerland | news aktuell GmbH - NTB Kommunikasjon","headline":"Strides Pharma Consolidates European Business-to-Business Operations in Switzerland | news aktuell GmbH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOQjdOU2Y2RHVCV29BZXR6X3R0bVZrUTI3Z21lbEZEZXRkdDlXVEtrSVBWSXNjZm1UZUtIbWlSak5OTkpWNzE5czBsc2pWZl9VRG5IemdEWmhDNlU2ODlMX3VVSy0tTUlDaGNSRXhPMkhfZVlYNlVBcXk5b2VDMnZraWRfU0UtRndXYlROT1pHc2pQdUlrMXRjbFJGTmhucnFaanJJ0gFWQVVfeXFMT2lXMU5ScXVLYkVKdTdaNHkySjBBSW0wMFdIZmRBVzFmUHcyNDVvQVk0M1R3ZG5sOFd1QkRHeTBDVWVabkZ0Y2cxSHl2TVEtclZ4TUJWenc?oc=5","date":"2024-01-26","type":"patent","source":"Law360","summary":"Generic-Drug Co. Concedes Infringement In Pfizer Heart Med Row - Law360","headline":"Generic-Drug Co. Concedes Infringement In Pfizer Heart Med Row - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNVVQtY0dFOURZbERyT1FGZV9oV3BaSEdnZklaTndHUlIzVzdvUlZWWUtPREVXY05HUTNyeE5SbWpMQ2RMbjlQQkdmakIzbkpzc01lTENmb29TME81M3N3cFcyMkxsNHUyWG8ycXJsY3A3cGxxZFMzMVlCWm5mS0hxd09fTEo3STZvZDlOR2lTT0xiVzZzU1dKWldPYzBpYm9TNEE?oc=5","date":"2024-01-26","type":"patent","source":"Bloomberg Law News","summary":"Pfizer’s First-Launched Vyndamax Patent Case Is Down to Validity - Bloomberg Law News","headline":"Pfizer’s First-Launched Vyndamax Patent Case Is Down to Validity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPSzBBWTg1Nm9uc1ZrQjluY0FONWVEZUFvY0dqWURCM3F1bjYzYVRoQ08xT2RSa3JMcE9PTnB0U0h4TUZDZlEwQm9SR0lQRmk1dU93X0R6ZW9IRzR3cmk1bXlWUVIwSXZKY1ZzcFdFaTd2VUFNMEM2MVRVYWxwUmVnRUJ6dEdEZ1BRVDVGcWdFcnN0MFVTc083NmhCb0dza3R4UHhpTWh6Rmp1SHpTel9RUk54bVZUdk5QeHdjMlZYLTJsUQ?oc=5","date":"2023-08-17","type":"patent","source":"TechTarget","summary":"Pfizer Sues Dexcel Pharmaceuticals Alleging Patent Infringement - TechTarget","headline":"Pfizer Sues Dexcel Pharmaceuticals Alleging Patent Infringement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOaHlOUjZfdDdPLUdLTkctaGxxcjA5ZlNZSEJuTG1vckRMdmZSMW9CZ0VadURSVGdOcEFqNnI0bGduakx1NGZKZXFYbTNXbGhOaWh4azYxeDlWYTBCT2tlcXFnY1dRcEV4T2N4ZTNpNmFDai04dGc3eGVjaHAxOEIwZkFsQ3pZQm5tcW1TbzI5TGVfWGxtUWFQRFcyR2h5QQ?oc=5","date":"2023-08-14","type":"regulatory","source":"PYMNTS.com","summary":"Pfizer Seeks to Delay Approval of Generic Version of Heart Drug - PYMNTS.com","headline":"Pfizer Seeks to Delay Approval of Generic Version of Heart Drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdFdUZUYwWGR2RnlFVkJGOWdnem1zb1RDcGp4YWlMRXUzV01rNTJmUDNlb0xGRm1RNHNOcEZhNUN4cTJ1NFotRjJxNm1nQU5lazlxVlRmQ25HZTN4bUFOQjlQZU5jZWUwd3AxV1pSNlNxSktvdFdZZWZWekx1cU1KNTZHTlp6TWVWVTk0SHROMjFxUmZQNmc5YmZPWlpMWE0?oc=5","date":"2023-08-11","type":"pipeline","source":"Bloomberg Law News","summary":"Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug - Bloomberg Law News","headline":"Pfizer, Scripps Sue to Block Copy of ‘Most Expensive’ Heart Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPUWcwMlVNb2piZlRxNjdULWNicUdHZ211NVVrdXlzVTh6WHpibkhzRGQtWEF2NWp3WGd5RE5qNGlmdDVGLXh5el9HZVVlUmhYbld1NWZsdGYzTmpELTlReWE0blgtVC1vamVfM0xwMFJlR3FkQ280NE81T0tWcWVpeHJWbzlJM0pxbzFRR29hYmYzU0E?oc=5","date":"2018-11-25","type":"pipeline","source":"Globes - Israel Business News","summary":"Teva's loss is Israeli pharma industry's gain - Globes - Israel Business News","headline":"Teva's loss is Israeli pharma industry's gain - Globes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPVGJPWEYxaU0zZGw4NzREcHhGQTExNjhUb3JKTHY4QjNVd0pNWWdleEhRb1ZZZHZVZWczN3NrR0xSTVhDYmFNcll5V3d1U3JtSlN0WFpXVmJhMjFsRDNoU01yZkJDLTBYSUpjSm5WM0ZNd1hBNWZEZnprRWRCalpFQ3RjV2swNHI2M3kwekFEVGxwTTIzTXNFMHNGUThCaFRmb0dmYkdWa202SUVfNzFha2lLb2taSGx5a1pPMUxfNkxNZUIwMTlIQk0yMlhUc3BLVFBkQ1RodksyVjhxMUdzbi1BREJvZWJDa3pKSkRCLTg?oc=5","date":"2014-08-05","type":"pipeline","source":"prnewswire.com","summary":"Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd. - prnewswire.com","headline":"Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPQnlwM19GUnNWMDZPRlNXTXZNUHlxaHVFZ2RJWXlBMHZseXl2U3dFbXVBTmZPc1I4WldWbHVUNjZKSG9QSGRfT01EMEg2N0tsUWVCdWNLcHBoYzlFV3RmT0F6UlBORjRtcTM5eFctYXprSl9pVGUxWEw4N2txQ1JxVmF0TGtUZw?oc=5","date":"2012-08-07","type":"pipeline","source":"Medical Professionals Reference","summary":"PerioChip Now Available for Periodontal Disease - Medical Professionals Reference","headline":"PerioChip Now Available for Periodontal Disease","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}